Methods for categorizing patients

Details Methods for categorizing patients Methods for categorizing patients

2006-07-25

2006-07-25

Rawlings, Stephen L. (Department: 1643)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C536S023400, C536S023500

Reexamination Certificate

active

07081516

ABSTRACT:
The disclosure provides, among other things, molecular markers for categorizing the neoplastic state of a patient, methods for using the molecular markers in diagnostic tests, nucleic acid and amino acid sequences related to the molecular markers, reagents for detection of molecular markers, and methods for identifying candidate molecular markers in highly parallel gene expression data.

REFERENCES:
patent: 2003/0232350 (2003-12-01), Afar et al.
patent: 2004/0002120 (2004-01-01), Kekuda et al.
patent: 2004/0005563 (2004-01-01), Mack et al.
patent: WO 99/38881 (1999-08-01), None
patent: WO 01/75067 (2001-10-01), None
patent: WO 01/90357 (2001-11-01), None
patent: WO 02/21996 (2002-03-01), None
patent: WO 02/30268 (2002-04-01), None
patent: WO 02/50301 (2002-06-01), None
patent: WO 02/068677 (2002-09-01), None
De Plaen E, et al. Immunogenetics. 1994; 40: 360-9.
Burgess WH, et al. J Cell Biol Nov. 1990; 111 (5 Pt 1): 2129-38.
Bowie JU, et al. Science Mar. 16, 1990; 247 (4948): 1306-10.
Lazar E, et al. Mol Cell Biol Mar. 1988; 8 (3): 1247-52.
Skolnick J, et al. Trends Biotechnol Jan. 2000; 18 (1): 34-9.
Takada I, et al. Mol. Endocrinol. 2000; 14 (5): 733-40.
Guo HH, et al. Proc. Natl. Acad. Sci. USA. Jun. 22, 2004; 101 (25): 9205-10.
Alon, U. et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. PNAS 96, 745-6750 (Jun. 1999).
Bieller, A. et al. Isolation and Characterization of the Human Forkhead Gene FOXQ1. DNA Cell Biol. 20, 555-561 (2001).
Deng, G. et al. Methylation of CpG in a Small Region of the hMLH1 Promoter Invariably Correlates with the Absence of Gene Expression. Cancer Res. 59. 2029-2033 (May 1, 1999).
Esteller, M. et al. Detection of Aberrant Promoter Hypermethylation of Tumor Suppressor Genes in Serum DNA from Non-Small Cell Lung Cancer Patients. Cancer Res. 59, 67-70 (Jan. 1, 1999).
GenBank Accession No. W07459 (Apr. 25, 1996).
GenBank Accession No. AI357412 (Jan. 6, 1999).
GenBank Accession No. AI590539 (Apr. 9, 1999).
GenBank Accession No. AI8707082 (Jul. 21, 1999).
GenBank Accession No. BAA92054 (Feb. 16, 2000).
GenBank Accession No. AY007815 (Aug. 29, 2000).
GenBank Accession No. AAG41062 (Aug. 29, 2000).
GenBank Accession No. XM—061091 (Jul. 31, 2002).
Hardy, R.G. et al. Aberrant P-cadherin expression is an early event in hyperplastic and dysplastic transformation in the colon. Gut 50, 513-514 (2002).
Herman, J.G. et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. PNAS 95, 6870-6875 (Jun. 1998).
Hibi, K. et al. Molecular Detection of Genetic Alterations in the Serum of Colorectal Cancer Patients. Cancer Res. 58, 1405-1407 (Apr. 1, 1998).
Kane, M.F. et al. Methylation of the hMLH1 Promoter Correlates with Lack of Expression of hMLH1 in Sporadic Colon Tumors and Mismatch Repair-defective Human Tumor Cell Lines. Cancer Res. 57, 808-811 (Mar. 1, 1997).
Kobayashi, A. et al. Molecular Cloning and Functional Characterization of a New Cap'n' Collar Family Transcription Factor Nrf3. J. Biol. Chem. 274, 6443-6452 (Mar. 5, 1999).
Markowitz, S. et al. Inactivation of the Type II TGF-$\beta$ Receptor in Colon Cancer Cells with Microsatellite Instability. Science 268, 1336-1338 (1995).
Radice, G.L. et al. Precocious Mammary Gland Development in P-Cadherin-deficient Mice. J. Cell Biol. 139, 1025-1032 (Nov. 17, 1997).
Scott, D.A. et al. Refining the DFNB7-DFNB11 deafness locus using intragenic polymorphisms in a novel gene, TMEM2. Gene 246, 265-274 (2000).
Shimoyama, Y. et al. Molecular Cloning of a Human Ca2+-dependent Cell-Cell Adhesion Molecule Homologous to Mouse Placental Cadherin: Its Low Expression in Human Placental Tissues. J. Cell Biol. 109, 1787-1794 (1989).
Unigene Hs. 157601,Homo sapienstranscribed sequences.
Veigl, M.L. et al. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. PNAS 95, 8698-8702 (Jul. 1998).
Weber, G.F. The metastasis gene osteopontin: a candidate target for cancer therapy. Biochim. Biophys. Acta. 1552, 61-85 (2001).
Wines, M.E. et al. Identification of Mesoderm Development (mesd) Candidate Genes by Comparative Mapping and Genome Sequence Analysis. Genomics 88-98 (2001).
Wong, I.H.N. et al. Detection of Aberrant p16 Methylation in the Plasma and Serum of Liver Cancer Patients. Cancer Res. 59, 71-73 (Jan. 1, 1999).
Zhang, J.-S. et al. Keratin 23 (K23), a Novel Acidic Keratin, Is Highly Induced by Histone Deacetylase Inhibitors During Differentiation of Pancreatic Cancer Cells. Genes Chromosomes Cancer 30, 123-135 (2001).
Srivastava et al., “Biomarkers for Early Detection of Colon Cancer,” Clinical Cancer Research 7:1118-1126 (2001).

Affiliated with

Also associated with

Rating

Methods for categorizing patients does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for categorizing patients, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for categorizing patients will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3529928